GlobeNewswire Inc.··NaConnect Biopharma Advances Respiratory Pipeline With $20M Raise, Q1 Results
Connect Biopharma raised $20.2M and reports positive Phase 2 respiratory data with topline results expected mid-2026. Cash runway extends to H2 2027.
CNTBPhase 2 clinical trialclinical-stage